Answer
Votrient (pazopanib hydrochloride) is contraindicated in patients with hypersensitivity to its active substance or any excipient listed in section 6.1.
Sources for this answer
- Votrient 200 mg and 400 mg film coated tabletsNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.3 Contraindications · Version 36Document updated
Sources checked